ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the first use of the company’s renal denervation catheter and generator system, as part of a feasibility study of the new technology. The technology was developed as a treatment for resistant hypertension (high blood pressure that is not well controlled by drug therapy). Prof. Stephen Worthley, Helpman Chair of Cardiovascular Medicine at the University of Adelaide, performed the first procedure at the Royal Adelaide Hospital in South Australia.
